We are live on ! Find out more
OA

Oxbow Advisors Portfolio holdings

AUM $1.18B
1-Year Est. Return 28.15%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+28.15%
3 Year Est. Return
+72.79%
5 Year Est. Return
+88.47%
10 Year Est. Return
+169.66%
AUM
$983M
AUM Growth
+$21.5M
Cap. Flow
+$46.1M
Cap. Flow %
4.69%
Top 10 Hldgs %
25.54%
Holding
314
New
22
Increased
118
Reduced
71
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 13.41%
2 Energy 13.36%
3 Financials 8.37%
4 Consumer Discretionary 6.7%
5 Communication Services 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
26
Accenture
ACN
$89.9B
$12.2M 1.24%
38,055
+618
+2% +$201K
ORLY icon
27
O'Reilly Automotive
ORLY
$72.4B
$12.1M 1.23%
297,555
+4,020
+1% +$161K
NOW icon
28
ServiceNow
NOW
$102B
$11.4M 1.16%
91,525
+1,595
+2% +$193K
MPLX icon
29
MPLX
MPLX
$59.5B
$10.9M 1.11%
382,199
+45,975
+14% +$1.3M
OHI icon
30
Omega Healthcare
OHI
$15.4B
$10.7M 1.09%
356,834
+42,194
+13% +$1.45M
NKE icon
31
Nike
NKE
$61.9B
$10.2M 1.03%
69,962
+856
+1% +$140K
MMP
32
DELISTED
Magellan Midstream Partners, L.P.
MMP
$10.1M 1.03%
221,781
+23,149
+12% +$1.1M
NTR icon
33
Nutrien
NTR
$32.7B
$10M 1.02%
154,453
+47,050
+44% +$2.88M
FNV icon
34
Franco-Nevada
FNV
$41.4B
$9.99M 1.02%
76,883
+68,633
+832% +$10.1M
MPT
35
Medical Properties Trust
MPT
$2.89B
$9.59M 0.98%
477,906
+10,042
+2% +$206K
UL icon
36
Unilever
UL
$131B
$9.43M 0.96%
154,617
+9,074
+6% +$578K
MRK icon
37
Merck
MRK
$324B
$9.41M 0.96%
125,298
+1,010
+0.8% +$76.8K
MCO icon
38
Moody's
MCO
$81.7B
$9.03M 0.92%
25,417
+1,051
+4% +$396K
USB.PRP icon
39
US Bancorp Series K Preferred Stock
USB.PRP
$490M
$8.72M 0.89%
323,896
+35,673
+12% +$989K
HR icon
40
Healthcare Realty
HR
$7.42B
$8.69M 0.88%
292,869
+10,280
+4% +$300K
LMT icon
41
Lockheed Martin
LMT
$134B
$8.63M 0.88%
25,015
+1,378
+6% +$499K
DSTL icon
42
Distillate US Fundamental Stability & Value ETF
DSTL
$1.91B
$8.6M 0.87%
210,003
+30,815
+17% +$1.3M
AMT icon
43
American Tower
AMT
$77.7B
$8.46M 0.86%
31,886
+1,106
+4% +$315K
NVS icon
44
Novartis
NVS
$295B
$8.4M 0.85%
102,720
+4,011
+4% +$361K
DVY icon
45
iShares Select Dividend ETF
DVY
$24B
$8.29M 0.84%
72,276
+3,822
+6% +$447K
JPST icon
46
JPMorgan Ultra-Short Income ETF
JPST
$40B
$8.26M 0.84%
162,814
+4,485
+3% +$227K
RYN icon
47
Rayonier
RYN
$6.49B
$7.92M 0.81%
244,831
+11,093
+5% +$372K
PYPL icon
48
PayPal
PYPL
$49.5B
$7.37M 0.75%
28,320
+2,613
+10% +$741K
DOC
49
DELISTED
PHYSICIANS REALTY TRUST
DOC
$7.34M 0.75%
416,811
+20,554
+5% +$380K
VLO icon
50
Valero Energy
VLO
$89.8B
$7.34M 0.75%
104,002
+99,362
+2,141% +$6.61M

Similar funds

Oxbow Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Oxbow Advisors held 314 positions worth $983M, up 2.2% from $962M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Oxbow Advisors deployed $46.1M of net new capital in Q3 2021, opening 22 new positions and adding to 118 existing holdings. Its largest new stake was Salesforce: 49,004 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $14.6M trimmed.

  • Oxbow Advisors's largest Q3 2021 buy was Salesforce: 49,004 shares worth $13.3M.
  • Oxbow Advisors added most to Berkshire Hathaway Class B in Q3 2021, an estimated $15.9M increase.
  • Oxbow Advisors's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $14.6M.
  • Oxbow Advisors fully exited TSMC in Q3 2021, selling an estimated $8.58M.
  • Oxbow Advisors's ten largest holdings make up 26% of its $983M portfolio in Q3 2021.
  • Oxbow Advisors opened 22 new positions and closed 24 in Q3 2021.
  • Oxbow Advisors's portfolio value rose 2.2% quarter-over-quarter to $983M.

Based on Oxbow Advisors's 13F filing for Q3 2021, filed 10 Nov 2021.